WHO publishes new global research agenda to strengthen paediatric clinical trials
On Nov. 6, 2025, the World Health Organization (WHO) released a technical report, The future of paediatric clinical trials…
On Nov. 6, 2025, the World Health Organization (WHO) released a technical report, The future of paediatric clinical trials…
On Oct. 30, 2025, the California Institute for Regenerative Medicine (CIRM) approved awarding $27 million through three grants…
On Oct. 29, 2025, Thermo Fisher announced it would buy privately held data management company Clario for up…
On Oct. 27, 2025, researchers from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health…
On Oct. 23, 2025, GSK announced the US Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf)…
On Oct. 23, 2025, CareDx announced the publication of the second study from Surveillance HeartCare Outcomes Registry (SHORE)…
On Oct. 18, 2025, GRAIL announced that positive performance and safety results from its registrational PATHFINDER 2 study…
On Oct. 14, 2025, researchers at Cincinnati Children’s in collaboration with Roche, have developed a next-generation human liver…
On Oct. 7, 2025, the World Health Organization (WHO) launched the Global Clinical Trials Forum (GCTF), a global,…
On Sept. 10, 2025, philanthropist Melinda French Gates announces she will invest $50 million in a women’s health…
On Sept. 3, 2025, C2N Diagnostics (C2N), a specialty diagnostics company announce that its early achievements while based…
On Aug. 29, 2025, the National Institutes of Health (NIH) announced it had awarded Duke University $69 million…
On Aug. 25, 2025, C2N Diagnostics (C2N) announced lower age limit addresses increasing calls from clinicians seeking access…
On Aug. 13, 2025, a research team led by investigators at the Translational Genomics Research Institute (TGen), part…
On Aug. 6, 2025, CareDx announced the publication of the Kidney Allograft Outcomes AlloSure Registry (KOAR) study in…
On Jul. 17, 2025, More than 35 leading experts highlight the risks posed by rapidly advancing capabilities at…
On Jul. 15, 2025, C2N Diagnostics (C2N), announces the launch of two new highly anticipated plasma assays for…
On Jun. 25, 2025, the National Institutes of Health (NIH) moved to reinstate about 900 grants that a…
On Jun. 20, 2025, Vertex Pharmaceuticals announced publication of updated data from the Phase 1/2 portion of the…
On Jun. 11, 2025, Novavax announced results of the initial cohort of its COVID-19-Influenza Combination (CIC) and stand-alone trivalent…
On Jun. 11, 2025, a study led by by University of Barcelona experts Carles J. Ciudad and Verònica…
On Mar. 27, 2025, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
On Jul. 30, 2024, a head-to-head comparison of six commercially available blood tests for Alzheimer’s disease led by…
On Jun. 27, 2024, C2N Diagnostics (C2N), has entered into a non-exclusive agreement with Mayo Clinic Laboratories, for…
On Jun. 13, 2024, the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic…
On May 1, 2024, researchers at the National Institutes of Health (NIH) announced a review in JAMA that…
On Feb. 24, 2024, C2N Diagnostics (C2N) announced the medical device registration from the United Kingdom’s Medicines and…
On Feb. 23, 2024, the California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative…
On Nov. 22, 2023, the U.S. Food and Drug Administration (FDA) issued the final guidance COVID-19: Developing Drugs…
On Jul. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $50.1 million to fund clinical-stage research…